nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Body temperature increased—Gemcitabine—lung cancer	0.000431	0.000431	CcSEcCtD
Meropenem—Renal failure—Methotrexate—lung cancer	0.00043	0.00043	CcSEcCtD
Meropenem—Rash—Vinorelbine—lung cancer	0.000428	0.000428	CcSEcCtD
Meropenem—Dermatitis—Vinorelbine—lung cancer	0.000428	0.000428	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—lung cancer	0.000428	0.000428	CcSEcCtD
Meropenem—Hypotension—Paclitaxel—lung cancer	0.000427	0.000427	CcSEcCtD
Meropenem—Headache—Vinorelbine—lung cancer	0.000426	0.000426	CcSEcCtD
Meropenem—Syncope—Docetaxel—lung cancer	0.000426	0.000426	CcSEcCtD
Meropenem—Asthma—Doxorubicin—lung cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Leukopenia—Docetaxel—lung cancer	0.000425	0.000425	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—lung cancer	0.000421	0.000421	CcSEcCtD
Meropenem—Sweating—Methotrexate—lung cancer	0.00042	0.00042	CcSEcCtD
Meropenem—Feeling abnormal—Cisplatin—lung cancer	0.000419	0.000419	CcSEcCtD
Meropenem—Paraesthesia—Etoposide—lung cancer	0.000419	0.000419	CcSEcCtD
Meropenem—Loss of consciousness—Docetaxel—lung cancer	0.000417	0.000417	CcSEcCtD
Meropenem—Dyspnoea—Etoposide—lung cancer	0.000416	0.000416	CcSEcCtD
Meropenem—Somnolence—Etoposide—lung cancer	0.000414	0.000414	CcSEcCtD
Meropenem—Cough—Docetaxel—lung cancer	0.000414	0.000414	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—lung cancer	0.000414	0.000414	CcSEcCtD
Meropenem—Insomnia—Paclitaxel—lung cancer	0.000413	0.000413	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—lung cancer	0.000413	0.000413	CcSEcCtD
Meropenem—Hypersensitivity—Irinotecan—lung cancer	0.000413	0.000413	CcSEcCtD
Meropenem—Paraesthesia—Paclitaxel—lung cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Hypertension—Docetaxel—lung cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—lung cancer	0.000408	0.000408	CcSEcCtD
Meropenem—Dyspnoea—Paclitaxel—lung cancer	0.000407	0.000407	CcSEcCtD
Meropenem—Somnolence—Paclitaxel—lung cancer	0.000406	0.000406	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—lung cancer	0.000405	0.000405	CcSEcCtD
Meropenem—Chest pain—Docetaxel—lung cancer	0.000404	0.000404	CcSEcCtD
Meropenem—Nausea—Vinorelbine—lung cancer	0.000404	0.000404	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—lung cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Dyspepsia—Paclitaxel—lung cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Body temperature increased—Cisplatin—lung cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Asthenia—Irinotecan—lung cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000401	0.000401	CcSEcCtD
Meropenem—Constipation—Etoposide—lung cancer	0.000399	0.000399	CcSEcCtD
Meropenem—Pain—Etoposide—lung cancer	0.000399	0.000399	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—lung cancer	0.000398	0.000398	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—lung cancer	0.000398	0.000398	CcSEcCtD
Meropenem—Decreased appetite—Paclitaxel—lung cancer	0.000397	0.000397	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—lung cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—lung cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—lung cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Asthenia—Gemcitabine—lung cancer	0.000392	0.000392	CcSEcCtD
Meropenem—Pain—Paclitaxel—lung cancer	0.000391	0.000391	CcSEcCtD
Meropenem—Constipation—Paclitaxel—lung cancer	0.000391	0.000391	CcSEcCtD
Meropenem—Confusional state—Docetaxel—lung cancer	0.000391	0.000391	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—lung cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Oedema—Docetaxel—lung cancer	0.000387	0.000387	CcSEcCtD
Meropenem—Anaphylactic shock—Docetaxel—lung cancer	0.000387	0.000387	CcSEcCtD
Meropenem—Pruritus—Gemcitabine—lung cancer	0.000386	0.000386	CcSEcCtD
Meropenem—Infection—Docetaxel—lung cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—lung cancer	0.000384	0.000384	CcSEcCtD
Meropenem—Diarrhoea—Irinotecan—lung cancer	0.000383	0.000383	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—lung cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—lung cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Shock—Docetaxel—lung cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Nervous system disorder—Docetaxel—lung cancer	0.00038	0.00038	CcSEcCtD
Meropenem—Thrombocytopenia—Docetaxel—lung cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—lung cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Infestation—Doxorubicin—lung cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—lung cancer	0.000378	0.000378	CcSEcCtD
Meropenem—Feeling abnormal—Paclitaxel—lung cancer	0.000377	0.000377	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—lung cancer	0.000376	0.000376	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000376	0.000376	CcSEcCtD
Meropenem—Hypersensitivity—Cisplatin—lung cancer	0.000375	0.000375	CcSEcCtD
Meropenem—Gastrointestinal pain—Paclitaxel—lung cancer	0.000374	0.000374	CcSEcCtD
Meropenem—Diarrhoea—Gemcitabine—lung cancer	0.000373	0.000373	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—lung cancer	0.000373	0.000373	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—lung cancer	0.000372	0.000372	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—lung cancer	0.000372	0.000372	CcSEcCtD
Meropenem—Dizziness—Irinotecan—lung cancer	0.000371	0.000371	CcSEcCtD
Meropenem—Urticaria—Etoposide—lung cancer	0.00037	0.00037	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—lung cancer	0.000369	0.000369	CcSEcCtD
Meropenem—Anorexia—Docetaxel—lung cancer	0.000369	0.000369	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—lung cancer	0.000368	0.000368	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—lung cancer	0.000368	0.000368	CcSEcCtD
Meropenem—Asthenia—Cisplatin—lung cancer	0.000365	0.000365	CcSEcCtD
Meropenem—Sweating—Doxorubicin—lung cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Urticaria—Paclitaxel—lung cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Hypotension—Docetaxel—lung cancer	0.000362	0.000362	CcSEcCtD
Meropenem—Body temperature increased—Paclitaxel—lung cancer	0.000361	0.000361	CcSEcCtD
Meropenem—Abdominal pain—Paclitaxel—lung cancer	0.000361	0.000361	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—lung cancer	0.000358	0.000358	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—lung cancer	0.000358	0.000358	CcSEcCtD
Meropenem—Vomiting—Irinotecan—lung cancer	0.000356	0.000356	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—lung cancer	0.000355	0.000355	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—lung cancer	0.000354	0.000354	CcSEcCtD
Meropenem—Rash—Irinotecan—lung cancer	0.000353	0.000353	CcSEcCtD
Meropenem—Dermatitis—Irinotecan—lung cancer	0.000353	0.000353	CcSEcCtD
Meropenem—Chills—Methotrexate—lung cancer	0.000353	0.000353	CcSEcCtD
Meropenem—Headache—Irinotecan—lung cancer	0.000351	0.000351	CcSEcCtD
Meropenem—Insomnia—Docetaxel—lung cancer	0.00035	0.00035	CcSEcCtD
Meropenem—Diarrhoea—Cisplatin—lung cancer	0.000348	0.000348	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—lung cancer	0.000348	0.000348	CcSEcCtD
Meropenem—Vomiting—Gemcitabine—lung cancer	0.000347	0.000347	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—lung cancer	0.000346	0.000346	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—lung cancer	0.000345	0.000345	CcSEcCtD
Meropenem—Somnolence—Docetaxel—lung cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Rash—Gemcitabine—lung cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Dermatitis—Gemcitabine—lung cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—lung cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Erythema—Methotrexate—lung cancer	0.000342	0.000342	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—lung cancer	0.000342	0.000342	CcSEcCtD
Meropenem—Headache—Gemcitabine—lung cancer	0.000342	0.000342	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—lung cancer	0.000341	0.000341	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—lung cancer	0.00034	0.00034	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—lung cancer	0.00034	0.00034	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—lung cancer	0.000338	0.000338	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—lung cancer	0.000337	0.000337	CcSEcCtD
Meropenem—Hypersensitivity—Paclitaxel—lung cancer	0.000337	0.000337	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—lung cancer	0.000335	0.000335	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—lung cancer	0.000335	0.000335	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—lung cancer	0.000334	0.000334	CcSEcCtD
Meropenem—Asthenia—Etoposide—lung cancer	0.000334	0.000334	CcSEcCtD
Meropenem—Nausea—Irinotecan—lung cancer	0.000333	0.000333	CcSEcCtD
Meropenem—Constipation—Docetaxel—lung cancer	0.000331	0.000331	CcSEcCtD
Meropenem—Pain—Docetaxel—lung cancer	0.000331	0.000331	CcSEcCtD
Meropenem—Back pain—Methotrexate—lung cancer	0.000331	0.000331	CcSEcCtD
Meropenem—Pruritus—Etoposide—lung cancer	0.00033	0.00033	CcSEcCtD
Meropenem—Asthenia—Paclitaxel—lung cancer	0.000328	0.000328	CcSEcCtD
Meropenem—Nausea—Gemcitabine—lung cancer	0.000324	0.000324	CcSEcCtD
Meropenem—Vomiting—Cisplatin—lung cancer	0.000323	0.000323	CcSEcCtD
Meropenem—Pruritus—Paclitaxel—lung cancer	0.000323	0.000323	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—lung cancer	0.000322	0.000322	CcSEcCtD
Meropenem—Rash—Cisplatin—lung cancer	0.000321	0.000321	CcSEcCtD
Meropenem—Dermatitis—Cisplatin—lung cancer	0.00032	0.00032	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—lung cancer	0.000319	0.000319	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—lung cancer	0.000319	0.000319	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—lung cancer	0.000317	0.000317	CcSEcCtD
Meropenem—Anaemia—Methotrexate—lung cancer	0.000316	0.000316	CcSEcCtD
Meropenem—Diarrhoea—Paclitaxel—lung cancer	0.000313	0.000313	CcSEcCtD
Meropenem—Malaise—Methotrexate—lung cancer	0.000308	0.000308	CcSEcCtD
Meropenem—Dizziness—Etoposide—lung cancer	0.000308	0.000308	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—lung cancer	0.000307	0.000307	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—lung cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—lung cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—lung cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Chills—Doxorubicin—lung cancer	0.000305	0.000305	CcSEcCtD
Meropenem—Dizziness—Paclitaxel—lung cancer	0.000302	0.000302	CcSEcCtD
Meropenem—Nausea—Cisplatin—lung cancer	0.000302	0.000302	CcSEcCtD
Meropenem—Cough—Methotrexate—lung cancer	0.000299	0.000299	CcSEcCtD
Meropenem—Vomiting—Etoposide—lung cancer	0.000296	0.000296	CcSEcCtD
Meropenem—Erythema—Doxorubicin—lung cancer	0.000296	0.000296	CcSEcCtD
Meropenem—Rash—Etoposide—lung cancer	0.000294	0.000294	CcSEcCtD
Meropenem—Dermatitis—Etoposide—lung cancer	0.000294	0.000294	CcSEcCtD
Meropenem—Headache—Etoposide—lung cancer	0.000292	0.000292	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—lung cancer	0.000292	0.000292	CcSEcCtD
Meropenem—Chest pain—Methotrexate—lung cancer	0.000291	0.000291	CcSEcCtD
Meropenem—Tension—Doxorubicin—lung cancer	0.000291	0.000291	CcSEcCtD
Meropenem—Vomiting—Paclitaxel—lung cancer	0.000291	0.000291	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—lung cancer	0.00029	0.00029	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000289	0.000289	CcSEcCtD
Meropenem—Rash—Paclitaxel—lung cancer	0.000288	0.000288	CcSEcCtD
Meropenem—Dermatitis—Paclitaxel—lung cancer	0.000288	0.000288	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—lung cancer	0.000288	0.000288	CcSEcCtD
Meropenem—Back pain—Doxorubicin—lung cancer	0.000287	0.000287	CcSEcCtD
Meropenem—Headache—Paclitaxel—lung cancer	0.000286	0.000286	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—lung cancer	0.000285	0.000285	CcSEcCtD
Meropenem—Confusional state—Methotrexate—lung cancer	0.000282	0.000282	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—lung cancer	0.000279	0.000279	CcSEcCtD
Meropenem—Asthenia—Docetaxel—lung cancer	0.000278	0.000278	CcSEcCtD
Meropenem—Infection—Methotrexate—lung cancer	0.000277	0.000277	CcSEcCtD
Meropenem—Nausea—Etoposide—lung cancer	0.000277	0.000277	CcSEcCtD
Meropenem—Pruritus—Docetaxel—lung cancer	0.000274	0.000274	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—lung cancer	0.000274	0.000274	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—lung cancer	0.000274	0.000274	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—lung cancer	0.000273	0.000273	CcSEcCtD
Meropenem—Agitation—Doxorubicin—lung cancer	0.000272	0.000272	CcSEcCtD
Meropenem—Nausea—Paclitaxel—lung cancer	0.000271	0.000271	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—lung cancer	0.000271	0.000271	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—lung cancer	0.00027	0.00027	CcSEcCtD
Meropenem—Malaise—Doxorubicin—lung cancer	0.000267	0.000267	CcSEcCtD
Meropenem—Anorexia—Methotrexate—lung cancer	0.000266	0.000266	CcSEcCtD
Meropenem—Syncope—Doxorubicin—lung cancer	0.000266	0.000266	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—lung cancer	0.000265	0.000265	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—lung cancer	0.000265	0.000265	CcSEcCtD
Meropenem—Hypotension—Methotrexate—lung cancer	0.000261	0.000261	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—lung cancer	0.00026	0.00026	CcSEcCtD
Meropenem—Cough—Doxorubicin—lung cancer	0.000258	0.000258	CcSEcCtD
Meropenem—Dizziness—Docetaxel—lung cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—lung cancer	0.000256	0.000256	CcSEcCtD
Meropenem—Insomnia—Methotrexate—lung cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—lung cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—lung cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—lung cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00025	0.00025	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—lung cancer	0.000249	0.000249	CcSEcCtD
Meropenem—Somnolence—Methotrexate—lung cancer	0.000248	0.000248	CcSEcCtD
Meropenem—Vomiting—Docetaxel—lung cancer	0.000246	0.000246	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—lung cancer	0.000246	0.000246	CcSEcCtD
Meropenem—Rash—Docetaxel—lung cancer	0.000244	0.000244	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—lung cancer	0.000244	0.000244	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—lung cancer	0.000244	0.000244	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—lung cancer	0.000243	0.000243	CcSEcCtD
Meropenem—Headache—Docetaxel—lung cancer	0.000243	0.000243	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—lung cancer	0.000242	0.000242	CcSEcCtD
Meropenem—Oedema—Doxorubicin—lung cancer	0.000242	0.000242	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—lung cancer	0.000241	0.000241	CcSEcCtD
Meropenem—Infection—Doxorubicin—lung cancer	0.00024	0.00024	CcSEcCtD
Meropenem—Pain—Methotrexate—lung cancer	0.000239	0.000239	CcSEcCtD
Meropenem—Shock—Doxorubicin—lung cancer	0.000238	0.000238	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—lung cancer	0.000237	0.000237	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—lung cancer	0.000237	0.000237	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—lung cancer	0.000236	0.000236	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—lung cancer	0.000235	0.000235	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—lung cancer	0.000234	0.000234	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—lung cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Nausea—Docetaxel—lung cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—lung cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—lung cancer	0.000228	0.000228	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—lung cancer	0.000226	0.000226	CcSEcCtD
Meropenem—Urticaria—Methotrexate—lung cancer	0.000222	0.000222	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—lung cancer	0.000221	0.000221	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—lung cancer	0.000221	0.000221	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—lung cancer	0.000219	0.000219	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—lung cancer	0.000217	0.000217	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—lung cancer	0.000216	0.000216	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—lung cancer	0.000215	0.000215	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—lung cancer	0.000213	0.000213	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—lung cancer	0.00021	0.00021	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000209	0.000209	CcSEcCtD
Meropenem—Pain—Doxorubicin—lung cancer	0.000207	0.000207	CcSEcCtD
Meropenem—Constipation—Doxorubicin—lung cancer	0.000207	0.000207	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—lung cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Asthenia—Methotrexate—lung cancer	0.0002	0.0002	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—lung cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—lung cancer	0.000198	0.000198	CcSEcCtD
Meropenem—Pruritus—Methotrexate—lung cancer	0.000198	0.000198	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—lung cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—lung cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—lung cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—lung cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Dizziness—Methotrexate—lung cancer	0.000185	0.000185	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—lung cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Vomiting—Methotrexate—lung cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Rash—Methotrexate—lung cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—lung cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Headache—Methotrexate—lung cancer	0.000175	0.000175	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—lung cancer	0.000173	0.000173	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—lung cancer	0.000171	0.000171	CcSEcCtD
Meropenem—Nausea—Methotrexate—lung cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—lung cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—lung cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—lung cancer	0.000154	0.000154	CcSEcCtD
Meropenem—Rash—Doxorubicin—lung cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—lung cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Headache—Doxorubicin—lung cancer	0.000151	0.000151	CcSEcCtD
Meropenem—Nausea—Doxorubicin—lung cancer	0.000144	0.000144	CcSEcCtD
